Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
ND-10 ER by Theialife Sciences for Myopia: Likelihood of Approval
ND-10 ER is under clinical development by Theialife Sciences and currently in Phase II for Myopia. According to GlobalData, Phase...